256 related articles for article (PubMed ID: 28829152)
1. Lymphoproliferative Disorders of the Gastrointestinal Tract.
Skinnider BF
Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
Burke JS
Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
Owens SR
Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
[TBL] [Abstract][Full Text] [Related]
4. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
6. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
8. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review.
Xia D; Morgan EA; Berger D; Pinkus GS; Ferry JA; Zukerberg LR
Am J Clin Pathol; 2019 Jan; 151(1):75-85. PubMed ID: 30212873
[TBL] [Abstract][Full Text] [Related]
9. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
10. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.
McElroy MK; Read WL; Harmon GS; Weidner N
Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278
[TBL] [Abstract][Full Text] [Related]
11. Lymph node involvement by enteropathy-like indolent NK-cell proliferation.
Dargent JL; Tinton N; Trimech M; de Leval L
Virchows Arch; 2021 Jun; 478(6):1197-1202. PubMed ID: 32696224
[TBL] [Abstract][Full Text] [Related]
12. NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease.
Wang R; Kariappa S; Toon CW; Varikatt W
Pathology; 2019 Apr; 51(3):338-340. PubMed ID: 30819538
[No Abstract] [Full Text] [Related]
13. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
14. NK cell enteropathy: a case report with 10 years of indolent clinical behaviour.
Isom JA; Arroyo MR; Reddy D; Joshi-Guske P; Al-Quran SZ; Li Y; Allan RW
Histopathology; 2018 Aug; 73(2):345-350. PubMed ID: 29474745
[TBL] [Abstract][Full Text] [Related]
15. [Chronic lymphoproliferative disorders].
Salles G
Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
[TBL] [Abstract][Full Text] [Related]
16. The recognition and classification of lymphoproliferative disorders of the gut.
O'Malley DP; Goldstein NS; Banks PM
Hum Pathol; 2014 May; 45(5):899-916. PubMed ID: 24613566
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach.
Pizzi M; Sabattini E; Parente P; Bellan A; Doglioni C; Lazzi S
Pathologica; 2020 Sep; 112(3):227-247. PubMed ID: 33179624
[TBL] [Abstract][Full Text] [Related]
18. Lymphomas and Amyloid in the Gastrointestinal Tract.
Ware AD; Wake LM; Fedoriw Y
Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
[TBL] [Abstract][Full Text] [Related]
19. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
Fey MF
Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
[TBL] [Abstract][Full Text] [Related]
20. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
